Navigation Links
Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer

KNOXVILLE, Tenn., Dec. 15 /PRNewswire/ -- Medical researchers with EDP Biotech Corporation (EDP) have captured national attention with their revolutionary new technology for a simple blood test to detect early-stage colon cancer.

Following the success of its pre-clinical trials for the ColoMarker(TM) assay, EDP has filed a patent on the biomarker, CA11-19, and all aspects of its use. Via an inexpensive blood test, ColoMarker(TM) will detect colon cancer in its earliest, most curable stages.

"American Cancer Society statistics show that when colon cancer is detected in its early stages, more than 90% of patients will survive. If not detected until the later stages, fewer than 10% will survive. ColoMarker(TM) detects colon cancer in these early, highly curable stages," says Kevin Jones, Ph.D., Chief Scientific Officer of EDP.

According to American Cancer Society statistics, fewer than 20% of Americans over the age of 50 who should be screened for colon cancer, actually are. With the use of ColoMarker(TM), a simple and inexpensive blood test, the number of people being screened would likely increase dramatically, leading to a decline in deaths due to colon cancer.

In pre-clinical trials, ColoMarker(TM) successfully detected the early stages (I, II, and III) of colon cancer. In tests of 2,370 blood samples, ColoMarker(TM) showed an accuracy rate of >99% for detecting colon cancer in these early stages. "ColoMarker(TM) could lead to a radical shift in the way we detect colon cancer," adds Dr. Jones.

National researchers who study colorectal cancer are closely monitoring emerging technologies such as ColoMarker(TM). Their findings are encouraging; just last week, the American Cancer Society, the National Cancer Institute, the Centers for Disease Control and Prevention and the North American Association of Central Cancer Registries released an optimistic report about the expected decline in deaths from colon cancer due to anticipated improvements in early screening methods.

Dr. Jones states, "The use of ColoMarker(TM) as a screening test could save tens of thousands of American lives every year and billions of dollars in healthcare costs." EDP Biotech is now moving forward expeditiously to get ColoMarker(TM) through the Food and Drug Administration clearance process.

For more information on ColoMarker(TM) or EDP Biotech Corporation, contact Jeff Hooper, Ackermann PR, and (865) 584-0550.

About EDP Biotech Corporation

EDP Biotech Corporation (EDP) is a medical device company focused on the development and sale of immunodiagnostic tests for both humans and animals. EDP utilizes more than 30 years of research and development in identification and purification of proteins present in the early stages of biological changes for production of in vitro diagnostic tests whose primary target is Early Detection Products.

    Jeff Hooper
    Ackermann PR
    (865) 584-0550

SOURCE EDP Biotech Corporation

SOURCE EDP Biotech Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. AVAC Says MDP 301 Microbicide Trial Results Disappointing, but Researchers and 9,400 Trial Volunteers Deserve Praise for Successful Trial
2. Neuro Kinetics & Military Researchers in Push To Improve Diagnosis & Treatment of Combat Brain Injuries
3. Sigma-Aldrich Announces SAGE(TM) Priority Partners Program; Seeks Researchers to Evaluate New Knockout Rat Models
4. New Effort to Battle Antibiotic Resistance Rallies Researchers Throughout Harvard University
5. Researchers Identify Two Genes as Potential Therapeutic Targets for Multiple Sclerosis
6. Researchers Find Common Respiratory Virus Hijacks Lung Cells to Stay Alive
7. Researchers Find High-Dose Therapy for Liver Disease Not Effective
8. Nucleix Researchers Discover DNA Evidence May Easily Be Falsified
9. Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
10. Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients
11. Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M. Finzi Memorial Student Summer Fellowships to Five Students
Post Your Comments:
(Date:6/23/2016)... MEDIA, Pa. , June 23, 2016 ... treatments in an outpatient dialysis facility.  Treatments are usually ... to 6 hours per visit, including travel time, equipment ... on a patient, but especially grueling for patients who ... residents of a skilled nursing and rehabilitation centers for ...
(Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
(Date:6/23/2016)... , June 23, 2016  The National Pharmaceutical ... joined the health policy research organization as its ... , MD, senior vice president and chief scientific ... representative on the NPC Board of Directors. ... that Mallinckrodt has joined us in support of ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
Breaking Medicine News(10 mins):